Protein modification by acrolein: relevance to pathological conditions and inhibition by aldehyde sequestering agents. - Wikidata - awgldk - TriplyDB

Protein modification by acrolein: relevance to pathological conditions and inhibition by aldehyde sequestering agents.

Protein modification by acrolein: relevance to pathological conditions and inhibition by aldehyde sequestering agents.

http://www.wikidata.org/entity/Q37909259

about

Protein lipoxidation: Detection strategies and challenges Acrolein-an α,β-Unsaturated Aldehyde: A Review of Oral Cavity Exposure and Oral Pathology Effects Biomonitoring Human Albumin Adducts: The Past, the Present, and the Future Acrolein contributes strongly to antimicrobial and heterocyclic amine transformation activities of reuterin Peanut protein structure, polyphenol content and immune response to peanut proteins in vivo are modulated by laccase.Environmental-stress-induced Chromatin Regulation and its Heritability Molecular mechanisms of acrolein toxicity: relevance to human disease A carnosine intervention study in overweight human volunteers: bioavailability and reactive carbonyl species sequestering effect.Cigarette smoke component acrolein modulates chromatin assembly by inhibiting histone acetylation.Acrolein-induced activation of mitogen-activated protein kinase signaling is mediated by alkylation of thioredoxin reductase and thioredoxin 1 Mechanisms Underlying Acrolein-Mediated Inhibition of Chromatin Assembly Transient receptor potential A1 receptor-mediated neural cross-talk and afferent sensitization induced by oxidative stress: implication for the pathogenesis of interstitial cystitis/bladder pain syndrome.Therapeutic potential of targeting lipid aldehydes and lipoxidation end-products in the treatment of ocular disease.Unsaturated aldehydes induce CCK secretion via TRPA1 in STC-1 cells.Acute cigarette smoke exposure impairs proteasome function in the lung.Localization of Acrolein-Lysine Adduct in Fibrovascular Tissues of Proliferative Diabetic Retinopathy.Effect of in vitro digestion on free α-dicarbonyl compounds in balsamic vinegars.Acrolein toxicity at advanced age: present and future.Albumin Cys34 adducted by acrolein as a marker of oxidative stress in ischemia-reperfusion injury during hepatectomy.Exposure assessment of process-related contaminants in food by biomarker monitoring.Acrolein, an α,β-unsaturated carbonyl, inhibits both growth and PSII activity in the cyanobacterium Synechocystis sp. PCC 6803.

P2860

Q26824737-CADD3DA7-011E-4EFB-BA85-B214AF5FD3B7 Q28069579-3B2EE649-F0FE-418F-B29B-809843116471 Q28468289-F3573ED4-50CC-4854-9D80-8B7C4DD03BDA Q28822008-8A0C8AE7-02FA-48CF-9199-83E526777991 Q30387570-06314E97-B57F-4191-A541-20CB6BE6F47F Q33914376-54186AA1-E661-44A8-ABEC-962ADAE0E8C5 Q35014415-FF121A47-571E-4511-A027-49A88D930B1D Q36970464-FB6F90DD-BDD4-455C-997C-A0EFAC58A916 Q37048366-AB8BD338-84DC-41FE-A13F-B44AAE4314EB Q37133504-926D609D-95C1-4D48-B538-E636F72A6043 Q37413682-B6B5B56A-5446-4912-9A94-4B092E9B9E7E Q37986932-59C241F3-5B66-4E1C-8137-8C79BAD773FA Q38077549-244F07B3-ACE1-4579-989E-5510A0DBC9D6 Q39041553-57C9E2F1-295B-4F2F-9F22-78B66301A44E Q39282499-AB791675-44BE-4519-ACCE-A1B27D5C2214 Q39718789-6C31F1D3-7A9B-4CD1-9D8E-1083874DED02 Q45775530-9C7651E3-226F-41D9-A573-69BB2E90229C Q46238083-8E727EB0-3AF0-407C-B01C-C9D78C5FCFF6 Q46561995-BC9209CC-8B6C-46D1-8E7A-A6B1A8280D20 Q47199602-E6857C5B-38B5-45A3-8F0B-0E321A883A77 Q47834959-05342C10-8105-4A0E-A768-EFF2A4AA95AE

P2860

Protein modification by acrolein: relevance to pathological conditions and inhibition by aldehyde sequestering agents.

http://www.wikidata.org/entity/Q37909259

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Protein modification by acrole ...... aldehyde sequestering agents.

@en

Protein modification by acrole ...... aldehyde sequestering agents.

@nl

type

label

Protein modification by acrole ...... aldehyde sequestering agents.

@en

Protein modification by acrole ...... aldehyde sequestering agents.

@nl

prefLabel

Protein modification by acrole ...... aldehyde sequestering agents.

@en

Protein modification by acrole ...... aldehyde sequestering agents.

@nl

P1433

Q37909259-526936FC-39E9-48C9-B103-25DC4901DEDE

P1476

Q37909259-FF47F4C0-223F-4D97-A37A-850CF46BFC4D

P2093

Q37909259-6391C344-05E5-4EC8-9F44-992708E98F89

Q37909259-84E731FD-0D5A-4B5A-8FBB-E624AD334D22

Q37909259-D1C90CC5-7293-4BAD-860D-0209EE4235CD

P2860

Q37909259-0125AB5C-FC24-4C04-AF3E-B184A43572A8

Q37909259-03232B2F-32A0-4BAF-9DA8-501B3AA47B2D

Q37909259-03F61106-25ED-4F1B-B4D4-89CC5C1F4DCF

Q37909259-047E7A57-4990-4A21-9C8A-10618E438586

Q37909259-0C9D23D9-00C4-4057-9B56-9DEA103DCEDF

Q37909259-0CE0778C-9350-4534-90ED-DB74BD3C74B8

Q37909259-0F25433F-695A-4DC8-878E-77031C952BB1

Q37909259-103CF9C2-A15D-4C46-A1B0-6A16C09342BA

Q37909259-10612CF6-43D6-4F36-B6D8-BFB6D74CE43A

Q37909259-1437D45C-EC13-464E-B112-F1C6B474176C

P304

Q37909259-9ABD4985-9498-4B8C-AE4C-8F92B7C7A089

P31

Q37909259-341F1D25-D338-4A44-B86E-CDC3F1BBF5BB

P356

Q37909259-E2FA5743-C863-4680-A268-D976257FA03D

P433

Q37909259-E6E4C909-8160-4C19-A57B-6FC99E1BB586

P478

Q37909259-F01A99E7-BB93-424E-BDC6-3BA2F5670E3B

P50

Q37909259-1B5116F8-5C30-47D8-8E20-8101D86ADA2D

Q37909259-9DF959AE-E7C9-4D15-914F-B4687C8CEA9F

Q37909259-D6E24A78-C75A-4182-A64B-0D02934FE06B

P577

Q37909259-B920A69A-1EAA-466F-8006-F39FB7C97DDE

P698

Q37909259-7E64ACC5-8824-4939-9E7E-1266FA351CBD

P356

P1433

Molecular Nutrition and Food Research

P1476

Protein modification by acrole ...... y aldehyde sequestering agents

@en

P2093

Giancarlo Aldini

http://www.w3.org/2001/XMLSchema#string

Marica Orioli

http://www.w3.org/2001/XMLSchema#string

Marina Carini

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-acrolein treatment improves behavioral outcome and alleviates myelin damage in experimental autoimmune encephalomyelitis mouse

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

Protective effects of the aqueous extract of Scutellaria baicalensis against acrolein-induced oxidative stress in cultured human umbilical vein endothelial cells

Exposure to acrolein by inhalation causes platelet activation

Protein modification by acrolein: formation and stability of cysteine adducts

Mass spectrometry for detection of 4-hydroxy-trans-2-nonenal (HNE) adducts with peptides and proteins.

Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures.

Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I.

Design, synthesis, and application of a hydrazide-functionalized isotope-coded affinity tag for the quantification of oxylipid-protein conjugates.

Acrolein inhibits cytokine gene expression by alkylating cysteine and arginine residues in the NF-kappaB1 DNA binding domain.

P304

1301-1319

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MNFR.201100182

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

Giancarlo Aldini

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21805620

http://www.w3.org/2001/XMLSchema#string